LSK BioPartners
Salt Lake City, US · Utah corporation
Founders & leadership
SC
Sung Chul KimNamed on SEC filing
HY
Ha Young KimNamed on SEC filing
AG
Anton GuethNamed on SEC filing
SW
Soo Whan ChoiNamed on SEC filing
AK
Alex KimNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$40M disclosed across 2 rounds · 2018–2019
▶$20MraisedMay 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$20MraisedMay 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sung Chul KimExecutive Officer, Director
- Ha Young KimDirector
- Anton GuethDirector
- Soo Whan ChoiExecutive Officer, Director
- Alex KimDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Apr 2019
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$20MraisedAug 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$20MraisedAug 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Weili ChengDirector
- Sung Chul KimExecutive Officer, Director
- Alex KimDirector
- Soo Whan ChoiExecutive Officer, Director
- Ha Young KimDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Jul 2018
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has LSK BioPartners raised?
- LSK BioPartners has disclosed $40M raised across 2 rounds.
- Where is LSK BioPartners headquartered?
- LSK BioPartners is headquartered in Salt Lake City, US.